Supplementary Table S5B from Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 study Article Swipe
Takafumi Koyama
,
Toshio Shimizu
,
Yuki Kojima
,
Kazuki Sudo
,
Hitomi Sumiyoshi Okuma
,
Tatsunori Shimoi
,
Hitoshi Ichikawa
,
Shinji Kohsaka
,
Ryo Sadachi
,
Akihiro Hirakawa
,
Akihiko Yoshida
,
Reiko Makihara Ando
,
Toshihide Ueno
,
Mitsuru Yanagaki
,
Naoko Matsui
,
Kenichi Nakamura
,
Noboru Yamamoto
,
Kan Yonemori
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/2159-8290.27025895
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/2159-8290.27025895
Whole-exome sequencing and RNA sequencing analyses of tumor tissue samples at pre-and post-treatment
Related Topics
Concepts
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- https://doi.org/10.1158/2159-8290.27025895
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4402821960
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4402821960Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2159-8290.27025895Digital Object Identifier
- Title
-
Supplementary Table S5B from Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 studyWork title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-09-16Full publication date if available
- Authors
-
Takafumi Koyama, Toshio Shimizu, Yuki Kojima, Kazuki Sudo, Hitomi Sumiyoshi Okuma, Tatsunori Shimoi, Hitoshi Ichikawa, Shinji Kohsaka, Ryo Sadachi, Akihiro Hirakawa, Akihiko Yoshida, Reiko Makihara Ando, Toshihide Ueno, Mitsuru Yanagaki, Naoko Matsui, Kenichi Nakamura, Noboru Yamamoto, Kan YonemoriList of authors in order
- Landing page
-
https://doi.org/10.1158/2159-8290.27025895Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2159-8290.27025895Direct OA link when available
- Concepts
-
Mdm2, Mechanism (biology), Sarcoma, Medicine, Genetics, Biology, Pathology, Philosophy, Epistemology, Cell cultureTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4402821960 |
|---|---|
| doi | https://doi.org/10.1158/2159-8290.27025895 |
| ids.doi | https://doi.org/10.1158/2159-8290.27025895 |
| ids.openalex | https://openalex.org/W4402821960 |
| fwci | 0.0 |
| type | supplementary-materials |
| title | Supplementary Table S5B from Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 study |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10253 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9811000227928162 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Sarcoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T11491 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.97079998254776 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | CAR-T cell therapy research |
| topics[2].id | https://openalex.org/T12534 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9670000076293945 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Protein Degradation and Inhibitors |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776192174 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5959909558296204 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q18028978 |
| concepts[0].display_name | Mdm2 |
| concepts[1].id | https://openalex.org/C89611455 |
| concepts[1].level | 2 |
| concepts[1].score | 0.49566638469696045 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q6804646 |
| concepts[1].display_name | Mechanism (biology) |
| concepts[2].id | https://openalex.org/C2778256501 |
| concepts[2].level | 2 |
| concepts[2].score | 0.4120143949985504 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q223911 |
| concepts[2].display_name | Sarcoma |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.30794915556907654 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C54355233 |
| concepts[4].level | 1 |
| concepts[4].score | 0.2121793031692505 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[4].display_name | Genetics |
| concepts[5].id | https://openalex.org/C86803240 |
| concepts[5].level | 0 |
| concepts[5].score | 0.16689661145210266 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[5].display_name | Biology |
| concepts[6].id | https://openalex.org/C142724271 |
| concepts[6].level | 1 |
| concepts[6].score | 0.14081454277038574 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[6].display_name | Pathology |
| concepts[7].id | https://openalex.org/C138885662 |
| concepts[7].level | 0 |
| concepts[7].score | 0.08360663056373596 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[7].display_name | Philosophy |
| concepts[8].id | https://openalex.org/C111472728 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0659940242767334 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q9471 |
| concepts[8].display_name | Epistemology |
| concepts[9].id | https://openalex.org/C81885089 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q189082 |
| concepts[9].display_name | Cell culture |
| keywords[0].id | https://openalex.org/keywords/mdm2 |
| keywords[0].score | 0.5959909558296204 |
| keywords[0].display_name | Mdm2 |
| keywords[1].id | https://openalex.org/keywords/mechanism |
| keywords[1].score | 0.49566638469696045 |
| keywords[1].display_name | Mechanism (biology) |
| keywords[2].id | https://openalex.org/keywords/sarcoma |
| keywords[2].score | 0.4120143949985504 |
| keywords[2].display_name | Sarcoma |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.30794915556907654 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/genetics |
| keywords[4].score | 0.2121793031692505 |
| keywords[4].display_name | Genetics |
| keywords[5].id | https://openalex.org/keywords/biology |
| keywords[5].score | 0.16689661145210266 |
| keywords[5].display_name | Biology |
| keywords[6].id | https://openalex.org/keywords/pathology |
| keywords[6].score | 0.14081454277038574 |
| keywords[6].display_name | Pathology |
| keywords[7].id | https://openalex.org/keywords/philosophy |
| keywords[7].score | 0.08360663056373596 |
| keywords[7].display_name | Philosophy |
| keywords[8].id | https://openalex.org/keywords/epistemology |
| keywords[8].score | 0.0659940242767334 |
| keywords[8].display_name | Epistemology |
| language | en |
| locations[0].id | doi:10.1158/2159-8290.27025895 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2159-8290.27025895 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5041593880 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5807-8458 |
| authorships[0].author.display_name | Takafumi Koyama |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Takafumi Koyama |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5046628885 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6632-0638 |
| authorships[1].author.display_name | Toshio Shimizu |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Toshio Shimizu |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5042828451 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1558-5510 |
| authorships[2].author.display_name | Yuki Kojima |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yuki Kojima |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5074229876 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4600-9428 |
| authorships[3].author.display_name | Kazuki Sudo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kazuki Sudo |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5011357939 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9639-7361 |
| authorships[4].author.display_name | Hitomi Sumiyoshi Okuma |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Hitomi Sumiyoshi. Okuma |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5017061681 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-3603-8575 |
| authorships[5].author.display_name | Tatsunori Shimoi |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Tatsunori Shimoi |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5015384004 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0142-2240 |
| authorships[6].author.display_name | Hitoshi Ichikawa |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Hitoshi Ichikawa |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5055160098 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8651-6136 |
| authorships[7].author.display_name | Shinji Kohsaka |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Shinji Kohsaka |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5006913863 |
| authorships[8].author.orcid | https://orcid.org/0009-0009-9536-1506 |
| authorships[8].author.display_name | Ryo Sadachi |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ryo Sadachi |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5022561314 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2580-7460 |
| authorships[9].author.display_name | Akihiro Hirakawa |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Akihiro Hirakawa |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5006840327 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-3373-0099 |
| authorships[10].author.display_name | Akihiko Yoshida |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Akihiko Yoshida |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5087090928 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5074-5690 |
| authorships[11].author.display_name | Reiko Makihara Ando |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Reiko Makihara. Ando |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5074950427 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-7408-7298 |
| authorships[12].author.display_name | Toshihide Ueno |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Toshihide Ueno |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5064216654 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-0664-5830 |
| authorships[13].author.display_name | Mitsuru Yanagaki |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Mitsuru Yanagaki |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5059787130 |
| authorships[14].author.orcid | https://orcid.org/0009-0008-7902-3761 |
| authorships[14].author.display_name | Naoko Matsui |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Naoko Matsui |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5101435028 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-3534-8296 |
| authorships[15].author.display_name | Kenichi Nakamura |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Kenichi Nakamura |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5030587345 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-0787-2851 |
| authorships[16].author.display_name | Noboru Yamamoto |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Noboru Yamamoto |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5021522674 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-7624-7611 |
| authorships[17].author.display_name | Kan Yonemori |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Kan Yonemori |
| authorships[17].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2159-8290.27025895 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table S5B from Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10253 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9811000227928162 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Sarcoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725, https://openalex.org/W2148612803 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/2159-8290.27025895 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2159-8290.27025895 |
| primary_location.id | doi:10.1158/2159-8290.27025895 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2159-8290.27025895 |
| publication_date | 2024-09-16 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.at | 10 |
| abstract_inverted_index.of | 6 |
| abstract_inverted_index.RNA | 3 |
| abstract_inverted_index.and | 2 |
| abstract_inverted_index.tumor | 7 |
| abstract_inverted_index.tissue | 8 |
| abstract_inverted_index.pre-and | 11 |
| abstract_inverted_index.samples | 9 |
| abstract_inverted_index.analyses | 5 |
| abstract_inverted_index.sequencing | 1, 4 |
| abstract_inverted_index.<p>Whole-exome | 0 |
| abstract_inverted_index.post-treatment</p> | 12 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 18 |
| citation_normalized_percentile.value | 0.33184049 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |